mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.2 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |